These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neurosurgical possibilities in the treatment of spastic paresis. Dieckmann G; Loew F; Palleske H Reconstr Surg Traumatol; 1972; 13():2-17. PubMed ID: 4560979 [No Abstract] [Full Text] [Related]
4. Phenol motor point block in the management of muscular hypertonia. Halpern D; Meelhuysen FE Arch Phys Med Rehabil; 1966 Oct; 47(10):659-64. PubMed ID: 5921287 [No Abstract] [Full Text] [Related]
5. [Phenol block in spastic palsy of the limb]. Murakami Y Seikei Geka; 1971 Mar; 22(3):221. PubMed ID: 5102570 [No Abstract] [Full Text] [Related]
6. Treatment of spasticity by phenol block. Rozin R; Magora F; Robin GC; Magora A Isr J Med Sci; 1970; 6(4):555-60. PubMed ID: 5536148 [No Abstract] [Full Text] [Related]
7. Treatment of spastic paresis. Young RR N Engl J Med; 1989 Jun; 320(23):1553-5. PubMed ID: 2725586 [No Abstract] [Full Text] [Related]
9. [Comparative clinical and humoral investigations in progressive paralysis including therapeutic viewpoints]. Stoerger R; Veil T Med Welt; 1965 Dec; 51():2875-6. PubMed ID: 5884857 [No Abstract] [Full Text] [Related]
10. Long-term follow-up on the use of diazepam in the treatment of spasticity. Peirson GA; Fowlks EW; King PS Am J Phys Med; 1968 Jun; 47(3):143-9. PubMed ID: 5301542 [No Abstract] [Full Text] [Related]
11. An introduction to trialing intrathecal baclofen in patients with hemiparetic spasticity: a description of 3 cases. Harned ME; Salles SS; Grider JS Pain Physician; 2011; 14(5):483-9. PubMed ID: 21927053 [TBL] [Abstract][Full Text] [Related]
12. A physiologic approach to the evaluation and the management of spasticity with procaine and phenol nerve block: including a review of the physiology of the stretch reflex. Khalili AA; Benton JG Clin Orthop Relat Res; 1966; 47():97-104. PubMed ID: 5923190 [No Abstract] [Full Text] [Related]
13. Peripheral nerve block and motor point block with phenol in the management of spasticity. Copp EP; Harris R; Keenan J Proc R Soc Med; 1970 Sep; 63(9):937-8. PubMed ID: 5477077 [No Abstract] [Full Text] [Related]
14. BoNT-A related changes of cortical activity in patients suffering from severe hand paralysis with arm spasticity following ischemic stroke. Veverka T; Hluštík P; Tomášová Z; Hok P; Otruba P; Král M; Tüdös Z; Zapletalová J; Herzig R; Krobot A; Kaňovský P J Neurol Sci; 2012 Aug; 319(1-2):89-95. PubMed ID: 22687958 [TBL] [Abstract][Full Text] [Related]
15. [Attenuating effect of a new pharmacological agent (Dantrolene sodium) on spasticity]. Ladd HW; Gingras G; Boucher J; Kazdan N; Keenan R Union Med Can; 1973 May; 102(5):1087-92. PubMed ID: 4576244 [No Abstract] [Full Text] [Related]
17. [Treatment of paresis following strokes with the drug Gamalon in the late recuperative and residual periods]. Stoliarova LG; Kadykov AS; Kistenev BA Klin Med (Mosk); 1972 Sep; 50(9):44-8. PubMed ID: 4652969 [No Abstract] [Full Text] [Related]
18. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens. Slawek J; Bogucki A; Reclawowicz D Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185 [TBL] [Abstract][Full Text] [Related]